Artículos del autor

solaci

Antiplatelet

Single Antiplatelet Therapy Following Percutaneous Left Atrial Appendage Occlusion

Percutaneous left atrial appendage occlusion (LAAO) has surged as an effective alternative to treat patients with atrial...
solaci -
Events

Artificial Intelligence in Complex PCI Cases – 2nd International Symposium of Cardiology

The Latin American Society of Interventional Cardiology invites the whole community to take part in the 2nd...
solaci -
Chronic Coronary Syndromes

LpA: 30-Year Cardiovascular Followup in Primary Prevention Cohorts

For years, treating dyslipidemia mainly focused on reducing LDL cholesterol (LDL-C) with statins, which had shown benefits...
solaci -
Coronary disease

Treatment of Recurrent In-Stent Restenosis with Drug-Eluting Stents: 10-Year Outcomes

In-stent restenosis (ISR) remains the main limitation in the percutaneous treatment of coronary artery disease, with a...
solaci -
Events

SOLACI@PCR Joint Session at EuroPCR 2024 – See You in Paris on May 14 thru 17

The Latin American Society of Interventional Cardiology will once more say here at EuroPCR 2024, undoubtedly one...
solaci -
Coronary disease

ERCTO Registry: Chronic Total Occlusion Treatment Outcomes

Chronic total occlusion (CTO) affect up to 20% of patients undergoing angiographic diagnostic tests. During the last...
solaci -
Carotid

Carotid Endarterectomy vs. Carotid Angioplasty in Symptomatic and Asymptomatic Patients: 30-Day Outcomes

Extracranial carotid artery disease represents 15 to 20% of all strokes. Carotid revascularization plays a role in...
solaci -
Coronary disease

EXCEL Study: Complete vs. Incomplete Revascularization

Regardless of whether it is attempted through percutaneous coronary intervention (PCI) or myocardial revascularization surgery (MRS), complete...
solaci -